BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26646032)

  • 1. Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.
    Goldstein BI; Lotrich F; Axelson DA; Gill MK; Hower H; Goldstein TR; Fan J; Yen S; Diler R; Dickstein D; Strober MA; Iyengar S; Ryan ND; Keller MB; Birmaher B
    J Clin Psychiatry; 2015 Nov; 76(11):1556-63. PubMed ID: 26646032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men.
    Su SC; Sun MT; Wen MJ; Lin CJ; Chen YC; Hung YJ
    Int J Psychiatry Med; 2011; 42(3):211-26. PubMed ID: 22439294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.
    Goldstein BI; Collinger KA; Lotrich F; Marsland AL; Gill MK; Axelson DA; Birmaher B
    J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):479-84. PubMed ID: 22040193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study.
    Glaus J; von Känel R; Lasserre AM; Strippoli MF; Vandeleur CL; Castelao E; Gholam-Rezaee M; Marangoni C; Wagner EN; Marques-Vidal P; Waeber G; Vollenweider P; Preisig M; Merikangas KR
    Psychol Med; 2018 Apr; 48(6):961-973. PubMed ID: 28929992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.
    Karthikeyan S; Dimick MK; Fiksenbaum L; Jeong H; Birmaher B; Kennedy JL; Lanctôt K; Levitt AJ; Miller GE; Schaffer A; Young LT; Youngstrom EA; Andreazza AC; Goldstein BI
    Brain Behav Immun; 2022 Feb; 100():278-286. PubMed ID: 34896179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance.
    Kunz M; Ceresér KM; Goi PD; Fries GR; Teixeira AL; Fernandes BS; Belmonte-de-Abreu PS; Kauer-Sant'Anna M; Kapczinski F; Gama CS
    Braz J Psychiatry; 2011 Sep; 33(3):268-74. PubMed ID: 21971780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.
    Li C; Birmaher B; Rooks B; Gill MK; Hower H; Axelson DA; Dickstein DP; Goldstein TR; Liao F; Yen S; Hunt J; Iyengar S; Ryan ND; Strober MA; Keller MB; Goldstein BI
    J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31365195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.
    Wang TY; Lee SY; Chen SL; Chung YL; Li CL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Hsieh TH; Chiu YC; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26865313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Study of Obesity Among Adolescents with Bipolar Disorder.
    Shapiro J; Mindra S; Timmins V; Swampillai B; Scavone A; Collinger K; Collins J; Goldstein BI
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):95-100. PubMed ID: 26771226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use disorders among adolescents with bipolar spectrum disorders.
    Goldstein BI; Strober MA; Birmaher B; Axelson DA; Esposito-Smythers C; Goldstein TR; Leonard H; Hunt J; Gill MK; Iyengar S; Grimm C; Yang M; Ryan ND; Keller MB
    Bipolar Disord; 2008 Jun; 10(4):469-78. PubMed ID: 18452443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients.
    Luo Y; He H; Zhang M; Huang X; Fan N
    Psychiatry Res; 2016 Oct; 244():19-23. PubMed ID: 27455146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study.
    Kargar M; Yousefi A; Mojtahedzadeh M; Akhondzadeh S; Artounian V; Abdollahi A; Ahmadvand A; Ghaeli P
    Swiss Med Wkly; 2014 Feb; 144():w13880. PubMed ID: 24554598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes in Children and Adolescents With Bipolar Disorder and Substance Use Disorder Comorbidity.
    Cardoso TA; Jansen K; Zeni CP; Quevedo J; Zunta-Soares G; Soares JC
    J Clin Psychiatry; 2017 Mar; 78(3):e230-e233. PubMed ID: 28068464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents.
    Hatch JK; Scola G; Olowoyeye O; Collins JE; Andreazza AC; Moody A; Levitt AJ; Strauss BH; Lanctot KL; Goldstein BI
    J Clin Psychiatry; 2017 Mar; 78(3):e286-e293. PubMed ID: 28199074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytes in peripheral blood in patients with bipolar disorder - Trait and state alterations and association with levels of cytokines and C-reactive protein.
    Munkholm K; Jacoby AS; Lenskjold T; Bruunsgaard H; Vinberg M; Kessing LV
    Psychiatry Res; 2018 Mar; 261():383-390. PubMed ID: 29353768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk.
    Goldstein TR; Birmaher B; Axelson D; Ryan ND; Strober MA; Gill MK; Valeri S; Chiappetta L; Leonard H; Hunt J; Bridge JA; Brent DA; Keller M
    Bipolar Disord; 2005 Dec; 7(6):525-35. PubMed ID: 16403178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.